Xynos Konstantinos 4
4 · Replimune Group, Inc. · Filed Dec 19, 2025
Insider Transaction Report
Form 4
Xynos Konstantinos
Chief Medical Officer
Transactions
- Award
Common Stock
2025-12-19+60,000→ 199,685 total
Footnotes (1)
- [F1]Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 50% of the RSUs will vest on November 15, 2026 and 50% of the RSUs will vest on November 15, 2027, subject to the Reporting Person's continuous service to the Issuer.